Botulinum Toxin Type A: Efficacy in the management of Lower Limb Spasticity in Children with Genetic Disorders

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Effect of Botulinum Toxin Type-A on Improvement of Muscle Function of Lower Limb in Children with Spastic Cerebral Palsy2024
2. 2ABSTRACT NUMBER: ESOC2026A440 SAFETY AND EFFICACY OF BOTULINUM TOXIN TYPE A FOR LOWER LIMB SPASTICITY IN POST-STROKE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS2026
3. 3Effectiveness and safety of <scp>abobotulinumtoxinA</scp> in pediatric lower limb spasticity: A phase <scp>IV</scp>, prospective, observational, multicenter study2025 · 1 citations
4. 4Three‐year outcomes of repeated botulinum neurotoxin A injections to the lower extremities in young children with spastic cerebral palsy in <scp>GMFCS</scp> levels I to <scp>III</scp>2025
5. 5Longer‐term imaging of muscle quality after routine <scp>BoNT</scp> ‐A care in cerebral palsy: Beyond muscle volume2026